The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial

Diabetes

Volumn 45, Issue 10, 1996, Pages 1289-1298

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0029785455     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.45.10.1289     Document Type: Review

References (34)

1. DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35:530-545, 1986
2. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. DCCT Research Group: Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18:1415-1427, 1995
4. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
5. Sipperstein MD, Browner WS: The case for moderate rather than tight glucose control in insulin-dependent diabetes mellitus. Clin Diabetes 13:7-9, 1995
6. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
7. Viberti G: A glycemic threshold for diabetic complications? N Engl J Med 332:1293-1294, 1995
8. Warram JH, Manson JE, Krowleski AS: Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med 332:1305-1306, 1995
9. DCCT Research Group: Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 18:361-375, 1995
10. DCCT Research Group: Assessment of hemoglobin Ale in the Diabetes Control and Complications Trial (DCCT). Clin Chem 33:2267-2271, 1987
11. DCCT Research Group: Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 102:647-661, 1995
12. DCCT Research Group: The effect of intensive diabetes treatment on progression of diabetic retinopathy in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. Arch Ophthalmol 113:36-51, 1995
13. Early Treatment Diabetic Retinopathy Study Research Group: Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS Report Number 12. Ophthalmology 98:823-833, 1991
14. DCCT Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial (DCCT). Kidney Int 47:1703-1720, 1995
15. DCCT Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy in the diabetes control and complications trial. Ann Intern Med 122:561-568, 1995
16. Schumer M, Pfeifer MA, Crum D, Burton G, Burton C, the DCCT Research Group: Diabetic autonomic neuropathy-part I: autonomic nervous system data analysis by a computerized central unit in a multicenter trial. Am J Med 85 (Suppl. 5A):137-143, 1988
17. Breslow NE, Day NE: Statistical Methods in Cancer Research. II. The Design and Analysis of Cohort Studies. Lyon, France, International Agency for Research on Cancer (London, Oxford Univ. Press). 1987, p. 120-142
18. Agresti A: Categorical Data Analysis. New York, Wiley, 1990, p. 84-91, 190-195
19. Fleming TR, Harrington DP: Counting Processes and Survival Analysis. New York, Wiley, 1991, p. 125-153
20. Ulm K: A statistical method for assessing a threshold in epidemiological studies. Stat Med 10:341-349, 1991
21. EURODIAB IDDM Complications Study Group: Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278-285, 1994
22. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154:2169-2178, 1994
23. Davis MD: Diabetic retinopathy. Diabetes Care 15:1844-1874, 1992
24. Riechard P: Are there any glycemic thresholds for the serious microvascular diabetic complications? J Diabetes Complications 9:25-30, 1995
25. Chase P, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O'Brien D: Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 251:1155-1160, 1989
26. Danne T, Weber B, Hartmann R, Enders I, Burger W, Hovener G: Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescence with diabetes: follow-up of the Berlin Retinopathy Study. Diabetes Care 17:1390-1396, 1994
27. Ferris FL: How effective are treatments for diabetic retinopathy? JAMA 269:1290-1291, 1993
28. Witkin SR, Klein R: Ophthalmologic care for persons with diabetes. JAMA 251:2534-2537, 1984
29. Sussman EJ, Tsiaras WG, Soper KA: Diagnosis of diabetic eye disease. JAMA 247:3231-3234, 1982
30. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA: Lower-extremity amputation in people with diabetes. Epidemiology prevention. Diabetes Care 12:24-31, 1989
31. Grunfeld C: Diabetic foot ulcers: etiology, treatment, and prevention. Adv Intern Med 37:103-132, 1991
32. Perneger TV, Brancati FL, Whelton PK, Klag MJ: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121:912-918, 1994
33. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
34. Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i:1430-1432, 1982